Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disaster Victims | 1 | 2016 | 1 | 0.500 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2016 | 17 | 0.500 |
Why?
|
| Sodium Compounds | 1 | 2015 | 9 | 0.450 |
Why?
|
| Benzoquinones | 1 | 2015 | 19 | 0.450 |
Why?
|
| Arsenites | 1 | 2015 | 18 | 0.450 |
Why?
|
| Child Abuse | 1 | 2016 | 222 | 0.400 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 393 | 0.380 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 302 | 0.370 |
Why?
|
| Antioxidants | 1 | 2015 | 334 | 0.370 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2025 | 281 | 0.370 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 492 | 0.350 |
Why?
|
| Oxidative Stress | 1 | 2015 | 798 | 0.320 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2025 | 677 | 0.280 |
Why?
|
| Inflammation | 1 | 2015 | 1480 | 0.260 |
Why?
|
| Postoperative Complications | 2 | 2025 | 3120 | 0.230 |
Why?
|
| Iron Overload | 1 | 2005 | 17 | 0.230 |
Why?
|
| Hydrocodone | 1 | 2025 | 36 | 0.230 |
Why?
|
| Ferritins | 1 | 2005 | 108 | 0.220 |
Why?
|
| Neuromuscular Agents | 1 | 2025 | 67 | 0.220 |
Why?
|
| Tics | 1 | 2025 | 53 | 0.220 |
Why?
|
| Postmenopause | 1 | 2005 | 149 | 0.220 |
Why?
|
| Obesity | 1 | 2016 | 2377 | 0.220 |
Why?
|
| Adenoidectomy | 1 | 2025 | 84 | 0.220 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2025 | 76 | 0.220 |
Why?
|
| Tic Disorders | 1 | 2025 | 83 | 0.220 |
Why?
|
| Acetaminophen | 1 | 2025 | 97 | 0.220 |
Why?
|
| Osteoporosis | 1 | 2005 | 136 | 0.210 |
Why?
|
| Turkey | 4 | 2016 | 65 | 0.200 |
Why?
|
| Botulinum Toxins | 1 | 2025 | 125 | 0.200 |
Why?
|
| Tonsillectomy | 1 | 2025 | 111 | 0.200 |
Why?
|
| Preoperative Care | 1 | 2025 | 357 | 0.200 |
Why?
|
| Laser Therapy | 1 | 2025 | 238 | 0.200 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2025 | 163 | 0.190 |
Why?
|
| Rett Syndrome | 1 | 2025 | 226 | 0.190 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2025 | 266 | 0.180 |
Why?
|
| Registries | 2 | 2025 | 1591 | 0.180 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2025 | 338 | 0.170 |
Why?
|
| Heart Arrest | 1 | 2025 | 374 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 468 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 1 | 2025 | 463 | 0.160 |
Why?
|
| Colistin | 2 | 2014 | 31 | 0.130 |
Why?
|
| Divorce | 1 | 2016 | 4 | 0.130 |
Why?
|
| Grief | 1 | 2016 | 21 | 0.120 |
Why?
|
| Parents | 1 | 2024 | 1104 | 0.120 |
Why?
|
| Male | 15 | 2025 | 64819 | 0.120 |
Why?
|
| Child | 9 | 2025 | 26096 | 0.120 |
Why?
|
| Cytoprotection | 1 | 2015 | 37 | 0.110 |
Why?
|
| Phenotype | 1 | 2024 | 4492 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 283 | 0.110 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2016 | 228 | 0.110 |
Why?
|
| Enterobacteriaceae | 1 | 2014 | 41 | 0.110 |
Why?
|
| Rats, Wistar | 1 | 2015 | 314 | 0.110 |
Why?
|
| Female | 15 | 2025 | 70740 | 0.100 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2014 | 58 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 435 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 344 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 3833 | 0.100 |
Why?
|
| Self Report | 1 | 2016 | 557 | 0.100 |
Why?
|
| Models, Animal | 1 | 2015 | 459 | 0.100 |
Why?
|
| Child, Preschool | 6 | 2025 | 14944 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 468 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1225 | 0.090 |
Why?
|
| beta-Lactamases | 1 | 2014 | 219 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2025 | 12858 | 0.090 |
Why?
|
| Humans | 17 | 2025 | 130912 | 0.080 |
Why?
|
| Bacteremia | 1 | 2014 | 423 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17483 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2016 | 1680 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 931 | 0.070 |
Why?
|
| Adult | 7 | 2025 | 31533 | 0.070 |
Why?
|
| Rats | 1 | 2015 | 3457 | 0.070 |
Why?
|
| Amino Acids | 2 | 2001 | 620 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 1790 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 677 | 0.060 |
Why?
|
| Risk Factors | 3 | 2016 | 10900 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 2558 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2025 | 277 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 134 | 0.050 |
Why?
|
| Tourette Syndrome | 1 | 2025 | 158 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2014 | 3432 | 0.050 |
Why?
|
| Adolescent | 4 | 2025 | 20812 | 0.050 |
Why?
|
| Iodine | 1 | 2003 | 23 | 0.050 |
Why?
|
| Dyspepsia | 1 | 2004 | 108 | 0.050 |
Why?
|
| Gene Duplication | 1 | 2024 | 364 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 225 | 0.050 |
Why?
|
| Middle Aged | 6 | 2025 | 28730 | 0.050 |
Why?
|
| Rickets | 1 | 2001 | 7 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2025 | 5095 | 0.040 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2001 | 49 | 0.040 |
Why?
|
| Gastritis | 1 | 2004 | 372 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2025 | 857 | 0.040 |
Why?
|
| Psychometrics | 1 | 2024 | 666 | 0.040 |
Why?
|
| Alleles | 1 | 2024 | 1705 | 0.040 |
Why?
|
| Indoles | 1 | 2001 | 201 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 1022 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 188 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2025 | 6443 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2025 | 873 | 0.040 |
Why?
|
| Cytokines | 1 | 2004 | 1340 | 0.030 |
Why?
|
| Lipids | 1 | 2001 | 566 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2950 | 0.030 |
Why?
|
| Aged | 3 | 2025 | 21134 | 0.030 |
Why?
|
| Young Adult | 2 | 2025 | 10037 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2001 | 570 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 2004 | 1355 | 0.030 |
Why?
|
| Helicobacter Infections | 1 | 2004 | 1298 | 0.030 |
Why?
|
| Carbapenems | 1 | 2014 | 47 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2001 | 744 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 170 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 4007 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 34275 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2014 | 88 | 0.030 |
Why?
|
| Infant | 2 | 2025 | 13210 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 560 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1587 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2014 | 1069 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2014 | 981 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 2866 | 0.020 |
Why?
|
| Biomarkers | 3 | 2003 | 3365 | 0.020 |
Why?
|
| Goiter | 1 | 2003 | 8 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 2003 | 17 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6862 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2004 | 206 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2003 | 56 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 2003 | 99 | 0.010 |
Why?
|
| Body Height | 1 | 2003 | 195 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 415 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 646 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2003 | 302 | 0.010 |
Why?
|
| Apolipoproteins | 1 | 2001 | 70 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 119 | 0.010 |
Why?
|
| Bone Development | 1 | 2000 | 55 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 237 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2000 | 243 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 2001 | 135 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2000 | 148 | 0.010 |
Why?
|
| Body Weight | 1 | 2003 | 986 | 0.010 |
Why?
|
| Collagen | 1 | 2000 | 295 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2001 | 240 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 957 | 0.010 |
Why?
|
| Cholesterol | 1 | 2001 | 543 | 0.010 |
Why?
|
| Calcium | 1 | 2001 | 1039 | 0.010 |
Why?
|
| Time Factors | 1 | 2000 | 6275 | 0.000 |
Why?
|